Acute severe asthma (status asthmaticus).
Agnihotri NT, Saltoun C.
Allergy Asthma Proc. 2019 Nov 1;40(6):406-409. doi: 10.2500/aap.2019.40.4258.
Natural history and mechanisms of COPD.
Lange P, Ahmed E, Lahmar ZM, Martinez FJ, Bourdin A.
Respirology. 2021 Apr;26(4):298-321. doi: 10.1111/resp.14007. Epub 2021 Jan 28.
Targeting the IL-5 pathway in eosinophilic asthma: A comparison of anti-IL-5 versus anti-IL-5 receptor agents.
Jackson DJ, Wechsler ME, Brusselle G, Buhl R.
Allergy. 2024 Nov;79(11):2943-2952. doi: 10.1111/all.16346. Epub 2024 Oct 12.
Optimal duration of exclusive breastfeeding.
Kramer MS, Kakuma R.
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD003517. doi: 10.1002/14651858.CD003517.pub2.
Benefits and risks of oxygen therapy during acute medical illness: Just a matter of dose!
Allardet-Servent J, Sicard G, Metz V, Chiche L.
Rev Med Interne. 2019 Oct;40(10):670-676. doi: 10.1016/j.revmed.2019.04.003. Epub 2019 May 1.
Noninvasive ventilation and respiratory physical therapy reduce exercise-induced bronchospasm and pulmonary inflammation in children with asthma: randomized clinical trial.
David MMC, Gomes ELFD, Mello MC, Costa D.
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618777723. doi: 10.1177/1753466618777723.
Bronchial Epithelial IgA Secretion Is Impaired in Asthma. Role of IL-4/IL-13.
Ladjemi MZ, Gras D, Dupasquier S, Detry B, Lecocq M, Garulli C, Fregimilicka C, Bouzin C, Gohy S, Chanez P, Pilette C.
Am J Respir Crit Care Med. 2018 Jun 1;197(11):1396-1409. doi: 10.1164/rccm.201703-0561OC.
Bronchial asthma control degree and the temperament structure according to the Eysenck model.
Witusik A, Mokros L, Kuna P, Pietras T.
Postepy Dermatol Alergol. 2020 Aug;37(4):559-565. doi: 10.5114/ada.2019.83216. Epub 2019 Mar 4.
Rapid identification of primary atopic disorders (PAD) by a clinical landmark-guided, upfront use of genomic sequencing.
Niehues T, von Hardenberg S, Velleuer E.
Allergol Select. 2024 Oct 2;8:304-323. doi: 10.5414/ALX02520E. eCollection 2024.
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study.
Pini L, Bagnasco D, Beghè B, Braido F, Cameli P, Caminati M, Caruso C, Crimi C, Guarnieri G, Latorre M, Menzella F, Micheletto C, Vianello A, Visca D, Bondi B, El Masri Y, Giordani J, Mastrototaro A, Maule M, Pini A, Piras S, Zappa M, Senna G, Spanevello A, Paggiaro P, Blasi F, Canonica GW, On Behalf Of The Sani Study Group.
J Clin Med. 2024 May 20;13(10):3013. doi: 10.3390/jcm13103013.
